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Purpose: To investigate senescent evidence in corneal endothelial cells (CECs) of the senescence-accelerated mouse
(SAM), which is considered a suitable animal model for the further study of the senescent mechanism in CECs.
Methods: Thirty-six male mice from a senescence resistant mouse strain (SAM R1) and a senescence-prone strain (SAM
P8) at various ages (1, 6, and 12 months) were analyzed in this study. The endothelial cell density (ECD) and cell viability
were detected using trypan blue and alizarin red dyes while the senescent cells were observed by senescence-associated
β-galactosidase (SA-β-Gal; pH 6.0) staining. In addition, ultrastructure was observed using an electron microscope. The
senescence-related genes (p16INK4a, p19ARF, p21WAF1/CIP1, and p53) in the CECs were visualized via immunohistochemistry
and  were  quantitatively  detected  using  real-time  polymerase  chain  reaction  (PCR).  Signal  proteins  of  phospho-
extracellular signal-regulated kinase 1/2 (p-ERK 1/2) were detected by western blot analysis.
Results: Our results indicated that the ECD values decreased with increasing age in both the SAM-R1 and SAM P8 series
where the values in the older SAM p8 series decreased even lower than in the older SAM R1 series. The mean decreased
rate was 2.276% per month in the SAM R1 and 2.755% per month in the SAM P8 series. In addition, changes in the
senescence-like ultrastructure were observed in the CECs of both strains, and the increase in the positive staining of SA-
β-Gal was observed in both strains as well. It is worth noting that such changes were more significant in the SAM P8
strain. Immunohistochemical detection assays indicated the expression of p-ERK 1/2, p16INK4a, p19ARF, p21WAF1/CIP1, and
p53 (nuclear localization for each) in each age group analyzed. Furthermore, the results of real-time PCR studies showed
an increase in the expression of p16INK4a mRNA as a function of age in the SAM R1 strain and in the early senescence
stage of the SAM P8 strain in addition to an increase in the expression of p21WAF1/CIP1 and p53 mRNA as a function of
age in the SAM P8 strain (no significant increase was observed in the SAM R1 strain). Additional results from western
blot analysis demonstrated an age-related increase in the quantity of the p-ERK 1/2 proteins in both strains.
Conclusions: The SAM R1 and SAM P8 strains represent suitable models for the study of CEC senescence in vivo. In
addition, the progression of cellular senescence in CECs occurs more quickly in the SAM P8 strain as opposed to the
SAM R1 strain. Our results also indicate that the p16INK4a signaling pathway may play a key role in the early stages of
senescence in CECs while the p53/p21WAF1/CIP1 signaling pathway may exert its principle effect in the late stages of
senescence in CECs. Further study is still required about the role of the mitogen-activated protein kinase (MAPK) signaling
cascade in the process of senescence in CECs.
The corneal endothelial cells (CECs) represent a single
layer of cells located between the corneal stroma and the
aqueous humor. This thin layer of cells performs important
functions such as serving as an ionic pump to maintain corneal
transparency and is also known to provide a barrier between
the corneal stroma and the aqueous humor. Although some
studies have indicated that the human corneal endothelial cells
(HCECs) retain the ability to proliferate ex vivo, the HCECs
are  in  fact  nonproliferative  in  vivo,  and  furthermore,
senescence-like changes have been shown to occur in CECs
while the endothelial cell density (ECD) has been shown to
decrease as a function of increasing age [1-4]. Additional
studies have indicated that accidental or surgical trauma in
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addition to disease may stimulate the ECD value to decrease
at a rapid rate [5,6], which may be related to an accelerated
progression  of  senescence  in  CECs  [7,8].  However,  the
mechanism of the pathological and physiologic senescence
process in CECs is still unclear.
Some studies have reported that senescence-related genes
such as p16INK4a, p21WAF1/CIP1, and p53 are expressed ex vivo
in the CECs from several species [9-12]. However, the aging
process may be quite different in vivo due to the influence of
the cultural, environmental, and passage stress. Our laboratory
has demonstrated that p16INK4a,p21WAF1/CIP1,P27KIP1, and p53
are all expressed in normal HCECs in vivo, and we conclude
from the age-dependent increase in p16INK4a expression that
the p16INK4a signaling pathway may play a key role in the
process  of  senescence  in  HCECs  [8].  However,  it  is  still
unclear the molecular mechanism of the aging process of
HCECs in vivo. Thus, a suitable animal model is essential for
further study.
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747The  senescence-accelerated  mouse  (SAM)  is  an
appropriate animal model [13,14]. This model consists of
accelerated  senescence-prone  strains  (SAM  P)  and
senescence-resistant strains (SAM R). The life span of the
SAM P and SAM R strains are approximately 358 days and
526 days, respectively. In addition, the SAM P strains are
characterized by an early onset and more rapid advancement
of senescence after a normal developmental process whereas
the SAM R strains are characterized by a persistent and normal
senescence process. They are widely used in the study of the
mechanisms  responsible  for  senescence  as  well  as  in
elucidating the pathogenesis and treatment of age-dependent
disorders  [15].  Each  SAM  strain  has  strain-speciﬁc,  age-
associated pathological phenotypes [16-24] such as the SAM
R1  strain  exhibits  a  decrease  in  the  production  of
photoreceptors and ganglion cells with an increase in age
while the SAM P8 exhibits changes in the retinal pigment
epithelium (RPE)-Bruch’s-choriocapillaris complex [25,26].
These two strains have also been studied for brain aging,
which is considered coevolution with eyes [27-29] However,
to our knowledge, there has been no study describing the
changes in the corneal endothelium of the SAM. Thus, we
want to verify the existence of senescence in the SAM P8 and
SAM R1 strains from the cell morphology and molecular
levels and evaluate whether this animal model is appropriate
for any further study of the senescent signal pathway in vivo.
METHODS
Animals: All of the experiments subscribed to the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research. The number of animals used in this study was
minimized as was any potential distress or discomfort to the
animals in accordance with the aforementioned regulations.
All of the mice were male and were divided into two groups
known as the SAM P8 (n=18) experimental group and the
SAM R1 (n=18) experimental group. Each group was studied
at various ages including 1, 6, and 12 months after birth. The
animals were obtained from the First Teaching Hospital of
Tianjin University of Traditional Chinese Medicine, Tianjin,
China.
Detection of the endothelial cell density, the viability, and the
exponential rate of cell loss: In this set of experiments, half
of each cornea was cut and stained with trypan blue and
alizarin red dyes [8]. Subsequently, five non-adjacent visual
an optical microscope with an ocular micrometer (Eclipse
E800; Nikon, Tokyo, Japan). The ECD and viability values
were calculated as the mean value of repeated measurements.
The  monthly  rate  of  endothelial  cell  loss  was  calculated
according   to   the   formula   reported   previously  (ECD2
rt) [30,31].
Electron microscopy: The second half of each corneal section
from above was ﬁxed in 4% buffered glutaraldehyde, washed
in a buffered solution of 0.2% sucrose-kakodyl for 4−10 h,
post-ﬁxed for 1 h in 1% osmium tetroxide, and was dehydrated
in graded alcohol concentrations. For analysis involving the
use of JEOL JSM-840 scanning electron microscopy (SEM)
(JEOL ,Tokyo, Japan), the quarter of specimens were replaced
with isoamyl acetate, air-dried, and sputter-coated with gold
before examination on the microscope. For analysis involving
transmission electron microscopy (TEM), semi-thin sections
(1 µm in thickness) of another quarter of specimens were
embedded in an epoxy resin for orientation purposes and were
subsequently stained with toluidine blue. In addition, ultrathin
sections were stained with uranyl acetate-lead citrate and were
examined  on  a  Hitachi  H-7000  transmission  electron
microscope  (Hitachi,  Tokyo,  Japan).  The  central  and
paracentral regions were also observed.
Senescence-associated  β-galactosidase  activity  staining:
Senescence-associated  (SA)-β-galactosidase  activity  was
detected as described previously [8]. For these analyses, half
of  each  cornea  was  washed  with  PBS,  fixed  in  4%
formaldehyde, and was incubated with a staining solution
consisting of 1 mg/ml X-Gal in dimethylformamide, 5 mM
potassium  ferrocyanide,  5  mM  potassium  ferricyanide,
150 mM NaCl, and 2 mM MgCl2 all in PBS at pH 6.0 for 12
h at 37 °C.
TABLE 1. PRIMERS USED FOR REAL-TIME POLYMERASE CHAIN REACTION.
Gene name Primer sequence Product length
P16INK4a F:AGGACCCCACTACCTTCTCCC 172 bp
R:AAATATCGCACGATGTCTTGATG
P19ARF F:GGCATGAACCGCCGACCTAT 101 bp
R:GGGCAGGCACAAACACGAAC
P21WAF1/CIP1 F:CCCGAGAACGGTGGAACT 115 bp
R:TGCAGCAGGGCAGAGGAAG
P53 F:CCCCAGGATGTTGAGGAGTTT 153 bp
R:TTGAGAAGGGACAAAAGATGACA
GAPDH F:CTGCCCAGAACATCATCCCT 119 bp
R:GGTCCTCAGTGTAGCCCAAGA
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fields of the endothelium from the central (as close as possible
to the center)  and  paracentral  regions  were  observed usingImmunohistochemical  localization  of  protein  in  the
senescence signaling pathway in corneal endothelial cells:
Half of each cornea was cut, immediately fixed in a solution
of  40  g/l  formaldehyde,  and  embedded  in  paraffin.  The
paraffin-fixed samples were sliced into 4 μm thick sections
and  subjected  to  immunohistochemical  staining  using  the
EliVisionTM plus kit (Maxim Corp, Fuzhou, China) according
to the manufacturer’s protocol. The primary antibodies were
the rabbit monoclonal anti-p-ERK 1/2 antibody (1:200; Cell
Signaling Technology, Beverly, MA), the mouse monoclonal
anti-p16 antibody (1:300; Santa Cruz Biotechnology, Santa
Cruz, CA), the rabbit polyclonal anti-p19 antibody (1:300;
Abcam,  Cambridge,  UK),  the  rabbit  polyclonal  anti-p21
(1:20;  Lab  Vision  Corp,  Fremont,  CA),  and  the  rabbit
polyclonal  anti-p53  antibody  (1:50,  Lab  Vision  Corp).  A
colored reaction was detected using the Diaminobenzidine
(DAB)  kit  (Boster,  Wuhan,  China).  In  addition,  negative
controls for all antigens consisted of tissue sections incubated
with PBS instead of a primary antibody. The slides were
photographed  using  a  Nikon  DXM  1200  digital  camera
(Nikon, Tokyo, Japan).
Quantitative real-time polymerase chain reaction detection of
the mRNA of senescence-related genes: The corneal tissues
obtained from each of the SAM strain groups at various ages
were placed on a culture plate under a surgical microscope
(Zeiss S4, Jena, Germany) with the endothelium side facing
upward. Descemet’s membrane including the endothelium
was immediately detached from the underlying stroma using
0.12 mm microforceps. Total RNA was then extracted from
the CECs using the RNeasy Mini kit (Qiagen GmbH, Hilden,
Germany)  according  to  the  manufacturer’s  protocol.
Transcription  of  the  corresponding  cDNA  was  performed
using a cDNA synthesis kit (MBI Fermentas, Heidelberg,
Germany) according to the manufacturer’s instructions. All of
the polymerase chain reactions (PCRs) were performed using
the SYBR green I Mastermix (Tiangen, Beijing, China) in a
final volume of 12 µl where the cDNA sample was tested by
the  ABI  Prism  7500  Real  Time  PCR  System  (Applied
Biosystems, Foster City, CA) according to the manufacturer’s
instructions.  The  expression  of  genes  was  normalized  to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The
primer sequences for these reactions are shown in Table 1.
Western blot analysis: The CECs were obtained as mentioned
above. Protein was extracted from CECs using the RIPA lysis
buffer (50mM Tris PH7.4, 150mM NaCl, 1%Triton X-100,
1% sodium deoxycholate, 0.1%SDS, sodium orthovanadate,
and sodium fluoride; Galen, Beijing, China) according to the
manufacturer’s instructions. Each of the prepared samples in
a final volume of 15 µl (containing a total of 50 µg of protein)
were run on a 10% SDS–PAGE gel for 1 h at 160 V and was
then  transferred  to  a  polyvinylidene  difluoride  (PVDF)
membrane (Millipore, Billerica, MA). The blots were blocked
in 5% non-fat dry milk dissolved in TBST ( 20mM Tris PH7.5,
0.5mM NaCl, 0.05%Tween-20) for at least 1 h and were then
incubated with the primary antibody in TBST for 1 h at room
temperature. The blots were then washed three times with
10 ml samples of TBST and were subsequently incubated for
1  h  at  room  temperature  with  a  horseradish  peroxidase-
conjugated  secondary  antibody  (Amersham  Biosciences,
Uppsala, Sweden) in TBST. The blots were washed again
three times with 10 ml of TBST. The membranes were then
developed  with  an  SuperSignal  West  Femto  Maximum
Sensitivity substrate (Pierce Biotechnology, Rockford, IL)
and  exposed  to  X-ray  film  (Kodak,  Rochester,  NY).
Immunoreactive  bands  were  visualized  via
chemiluminescence  and  quantified  using  NIH  Image  1.62
software (National Institutes of Health, Bethesda, MD). The
primary antibodies were the rabbit monoclonal anti-p-ERK
1/2 antibody and the rabbit anti-Erk1/2 antibody (1:2,000 and
1:1,000, respectively; Cell Signaling Technology).
Statistical analyses: The statistical differences of each sample
upon comparison between different strains and ages groups
Figure 1. Corneal endothelium of the SAM strains stained with alizarin red and trypan blue for detection of the cell morphology, density and
viability. A: The endothelium of a one-month-old specimen from the SAM R1 strain is shown. Most of the cells are regular hexagon.
Magnification: 400X. B: The endothelium of a six-month-old specimen from the SAM P8 strain shows a significant number of polygonal
cells. Magnification: 400X. C: The endothelium of a 12-month-old specimen from the SAM P8 strain is displayed. The arrows indicate the
hyperplasia of the tunica vasculosa on the endothelial surface layer. The covering of the tunica vasculosa causes most of the cells displayed
to look unclear. The blue lines (black arrow) indicate the hyperplastic blood vessel. Magnification: 100X.
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749were  analyzed  using  the  two-way  analysis  of  variance
(ANOVA) and Student-Newman-Keul's (SNK) test. All p
values  less  than  0.05  were  considered  to  be  statistically
significant.
RESULTS
Endothelial  cell  density  and  viability:  After  staining  with
trypan blue and alizarin red, the intercellular borders stained
red while the nuclei of damaged cells stained blue (Figure 1).
The ECD decreased in both SAM R1 and P8 strains, but the
decline in the P8 strain was faster (Figure 2). The cell viability
in each group was higher than 85%, and the exponential rate
of cell loss was shown in Table 2. The mean rate of endothelial
cell loss (from 1- to 12-month-old) of the SAM R1 strain was
2.276±0.71% per month, while that of the SAM P8 strain was
2.755±0.85% per month.
Ultrastructure: Examination of the TEM images showed that
in  the  one-month  samples  from  each  strain  group,  the
microvilli  and  organelles  of  the  endothelial  cell  were
abundant. The junction of the interlamination was tight. The
thickness of the endothelium and Descemet’s membrane were
uniform (Figure 3A,B), which were both of no significant
differences between the two strain groups (p=0.067 in Table
3, p=0.378 in Table 4) was found. In the six-month samples
Figure 2. Changes in the endothelial cell
density values at various ages for each
experimental group. The results indicate
a significant decrease in the ECD values
of  the  SAM  R1  strain  at  six  months
(p=0.010  versus  one-month-old
specimen) and at 12 months (p=0.000
versus  both  one-  and  six–month-old
specimens). There is also a significant
decrease in the ECD values of the SAM
P8 specimens at six months (p=0.000
versus one-month-old specimen) and at
12 months (p=0.000 versus both one-
and  six-month-old  specimens).  In
addition,  there  is  no  significant
difference  in  the  ECD  values  at  one
month between the SAM R1 and the
SAM P8 strains (p=0.293), but there is
a significant decrease in the ECD values
of  both  six-  and  12–month-old
specimens between the SAM R1 and the
SAM P8 strains (p=0.010 and p=0.042,
respectively).  The  results  indicate  the
decrease of ECD in SAM P8 is faster
than in SAM R1. An asterisks mark a
statistically  significant  difference
(p<0.05).
TABLE 2. CORNEAL ENDOTHELIAL CHANGES FOR ALL EXPERIMENTAL SUBJECTS.
Groups (strain, age
in months)
Number of fields
examined#
ECD 
2
Viability                  Exponential rate of
(%)                         cell loss (%/m)
R1 1 m 15 3160±114.02 96.0±2.0
R1 6 m 15 2900±158.11 92.8±1.48 1.717±1.55*
R1 12 m 15 2460±151.66 92.2±1.30 2.742±1.27**
P8 1 m 15 3060±151.66 93.4±2.30
P8 6 m 15 2640±114.02 94.4±1.95 2.953±1.31*
P8 12 m 15 2260±181.66 89.0±2.92 2.590±1.77**
In the table, m is the age in months. The hash mark (#) indicates that the number of fields examined came from three individual
corneas  in each experimental group. An asterisk means the exponential rate of cell loss rate is from the age of one month to the
age of six months. The double asterisk means the exponential rate of cell loss rate is from the age of six months to the age of
12 months.
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(cells/mm )of the SAM R1 strain, the microvilli and the organelles were
decreasing,  fewer  vacuoles  were  observed  in  the
interlamination  (Figure  3C),  and  the  thickness  of  the
Descemet’s membrane was significantly increased (p=0.005
in Table 4) while there were no significant changes in the
endothelium (p=0.078 in Table 3). In the six-month samples
Figure 3. Analysis of transmission electron microscope imaging. The cornea from one-month-old mice of the SAM R1 and the SAM P8
experimental groups are shown (A and B, respectively). The thickness of the endothelium was greater than or equal to the thickness of the
Descemet’s membrane. The microvilli were abundant (locations indicated by arrows). C: Analysis of six-month-old specimens from the SAM
R1 experimental group shows that the thickness of endothelium was also less than or equal to the thickness of the descemet’s membrane. D:
Analysis of six-month-old specimens from the SAM P8 experimental group shows that the thickness of the endothelium decreased significantly
and that many of the interstices were located in the interlamination. E: Analysis of 12-month-old specimens from the SAM R1 experimental
group showed that the thickness of the endothelium was uneven and that many of the interstices could be observed. F: Analysis of the 12-
month-old specimens from the SAM P8 experimental group showed that the thickness of endothelium was very thin. Scale bars: 1 μm. En:
endothelium; De: Descemet’s membrane; St: stroma.
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751obtained  from  the  SAM  P8  strain,  the  microvilli  and  the
organelles were significantly less well resolved, and much of
the interstices were in the interlamination (Figure 3D). The
thickness  was  significantly  decreased  in  the  endothelium
(p=0.000 in Table 3) while the thickness was significantly
increased in the Descemet’s membrane (p=0.000 in Table 4).
Similarly, in the 12-month-old samples, the microvilli and the
organelles  were  very  few  in  number,  the  interstices  were
larger  and  more  abundant  in  the  interlamination,  and  the
thickness of endothelium was uneven (Figure 3E,F), which
was significantly thinner (p=0.023 and p=0.014, respectively
in Table 3), while the thickness of Descemet’s membrane was
significant increased when compared to the six-month old
samples  (p=0.000  and  p=0.001,  respectively  in  Table  4).
However, no significant difference was found between the
two strains (p=0.953 in Table 4).
In addition, examination of the SEM images showed that
the one-month-old samples from each strain group had the
hexagonal  and  uniform  endothelial  cell  morphology  with
numerous microvilli located on the surface (Figure 4A,B). In
the  six-month-old  samples  from  both  strain  experimental
groups,  the  morphology  of  the  endothelial  cells  was
TABLE 3. THE THICKNESS OF THE CORNEAL ENDOTHELIUM LAY IN VARIOUS AGES OF EACH EXPERIMENTAL GROUP.
Groups 1 m (μm) 6 m (μm) 12 m (μm)
R1 1.60±0.22 (n=40) 1.31±0.29 (n=36, p=0.078
versus 1 m)
0.93±0.46 (n=38, *p=0.023
versus 6 m)
P8 1.90±0.23 (n=36) 0.96±0.38 (n=38, *p=0.000
versus 1 m)
0.54±0.38 (n=38, *p=0.014
versus 6 m)
p value (R1 versus P8) p=0.067 *p=0.031 *p=0.019
In the headings, m is the age  in months. In the body of the table, n is the number of fields examined from the three individual
specimens of each experimental group. The thickness of the corneal endothelium decreased significantly in the 12-month-old
in the R1 strain group while it decreased significantly in both the 6-month to 12-month-old specimens in the P8 strain group.
When comparing the two strain groups, the thicknesses of the corneal endothelium are significant thinner in 6-month- and 12-
month-old specimens of the P8 strain than in that of the R1 strain group.
TABLE 4. THE THICKNESS OF DESCEMET’S MEMBRANE OF THE CORNEA IN VARIOUS AGES OF EACH EXPERIMENTAL GROUP.
Groups 1 m (μm) 6 m (μm) 12 m (μm)
R1 1.03±0.16
   (n=40)
1.58±0.25 (n=36, *p=0.005
versus 1 m)
2.90±0.41 (n=38, *p=0.000
versus 6 m)
P8 1.20±0.14
   (n=36)
2.20±0.52 (n=38, *p=0.000
versus 1 m)
2.89±0.64 (n=38, *p=0.001
versus 6 m)
p value (R1 versus P8) p=0.378 *p=0.002 p=0.953
In the headings, m is the age  in months. In the body of the table, n is the number of fields examined from the three individual
specimens  of each experimental group. The thickness of Descemet’s membrane increased significantly in 6-month- and 12-
month-old specimens of both R1 and P8 strain groups. When comparing between the two strain groups, the thicknesses of
Descemet’s membrane are more significantly thickened in the six-month-old specimen of the P8 strain than in the six-month-
old specimen of the R1 strain group while no significant differences were seen between the 12-month-old specimens of the two
strain groups.
TABLE 5. THE PERCENTAGE OF HEXAGONAL CELLS OF THE CORNEAS IN VARIOUS AGES OF EACH EXPERIMENTAL GROUP.
Groups 1 m (%) 6 m (%) 12 m (%)
R1 84.11±11.17
    (n=15)
75.33±8.40 (n=15, p=0.062
versus 1 m)
61.11±7.93 (n=15, *p=0.003
versus 6 m)
P8 86.78±8.27
    (n=15)
65±10.10 (n=15, *p=0.000 versus
1 m)
51.67±11.86 (n=15, *p=0.006
versus 6 m)
p value (R1 versus P8) p=0.564 *p=0.029 *p=0.045
In the headings, m is the age  in months. In the body of the table, n is the number of fields examined from the three individual
specimens  of each experimental group. The percentage of hexagonal cells increased significantly in the 12-month-old specimen
of the R1 strain group while the percentage increased significantly in both the 6-month- to 12-month-old specimens of the P8
strain group. When comparing the two strain groups, the percentage of hexagonal cells are significantly higher in 6-month- and
12-month-old specimens of the P8 strain than in the specimens of the R1 strain group of the same ages.
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752characterized as being larger and pantomorphic where the
microvilli were fewer in number. Such changes were more
significant in the SAM P8 strain (Figure 4C,D). In the 12-
month-old samples from both strain groups, the cellular areas
were  even  larger  than  that  observed  at  six  months,  the
microvilli  were  less  numerous  than  that  observed  at  six
months, and a large number of pantomorphic cells were be
observed (Figure 4E,F) with such changes more significant in
the SAM P8 strain (Table 5).
Evaluation of the SA-β-Gal activity in corneal endothelial
cells: SA-β-Gal staining, which served as a marker of cellular
senescence, was performed and indicated very little activity,
if any, in the one-month-old CECs from each experimental
group  (Figure  5A,B).  However,  analysis  of  the  staining
tendencies  indicated  that  the  expression  increased  with
increasing age in the CECs from each strain group (Figure 5C-
F) with such changes more significant in the SAM P8 strain
when comparing the two strains (Table 6 and Figure 6).
Qualitative  immunohistochemical localization:
Immunohistochemical  staining  of  p-ERK  1/2,  p16INK4a,
p19ARF, p21WAF1/CIP1, and p53 revealed that all of these proteins
were expressed and were located in the nucleus of the CECs
in each experimental groups (Figure 7).
Real-time  polymerase  chain  reaction  of  the  senescence-
related  genes  in  corneal  endothelial  cells:  The  genes
responsible for expressing p16INK4a, p19ARF, p21WAF1/CIP1, and
p53 proteins in CECs were detected quantitatively using real-
time PCR. These data show that the relative expression of
p16INK4a increased significantly in the SAM R1 strain with
increasing age. Although we observed a significant increase of
p16INK4a expression from six months of age to 12 months in
the SAM P8 strain when compared to the value at one month,
the expression of p16INK4a had decreased at 12 months when
compared to the value at six months (Figure 8A). The relative
expression of p19ARF decreased significantly in the 12-month-
old samples from the SAM R1 strain. However, no significant
differences in the expression level were observed with the
SAM P8 strain as a function of increasing age (Figure 8B). In
addition,  the  relative  expression  of  p21WAF1/CIP1  and  p53
mRNA increased significantly in the SAM P8 strain with an
increase in age, but, again, a similar statistically significant
increase was not observed for the SAM R1 strain (Figure 8C-
E).
Western blot analysis of the MAPK signaling pathway in the
corneal endothelial cells as a function of age: The Erk1/2
proteins are the key proteins of the MAPK signaling pathway,
which  is  phosphorylated  and  subsequently  activated.  To
further  understand  the  activity  state  of  the  MAPK  signal
cascade as a function of the age of the CECs, we compared
the expression levels of the p-ERK 1/2 proteins at various ages
after birth. These data show that the expression of the p-ERK
1/2 protein increases at 12 months both in the SAM R1 and
SAM P8 strains (Figure 9A,B).
DISCUSSION
HCECs,  which  are  cells  that  play  important  roles  in
maintaining  the  structure  and  function  of  the  cornea,  are
unable to proliferate in vivo. The quantity of HCECs decrease
as aging progresses [32], and this tendency is coupled with
senescence-induced changes in cellular morphology [2-4].
Previous studies have also reported atrophic and degenerative
morphological  characteristics  in  the  endothelium  of  the
corneal graft that had resulted in late endothelial failure (LEF)
[5,6] or chronic corneal allograft dysfunction (CCAD) after
penetrating keratoplasty (PK) [33]. This was evidenced by a
decrease  in  endothelial  cell  counts,  the  observation  of
enlarged cells, irregularly shaped cells, cytoplasm loss, and
the appearance of vacuoles and binuclear cells. Moreover, the
ECD of the corneal grafts decreased at an accelerated rate
when  compared  to  healthy  corneas  [5,6].  All  sorts  of
observations and evidence have indicated that such corneal
diseases may be related to the accelerated senescence of the
CECs, which has become a major cause of late transplant
failure  [6,31].  However,  until  now,  the  physiologic  and
pathological mechanisms of the HCEC senescence signaling
pathways have not been elucidated.
Due to the lack of donors and to limitations in performing
human in vivo studies, an appropriate animal model is needed
to explore the process of senescence in CECs. The SAM has
certain features that may make it a potentially attractive model
for understanding cellular senescence and may in principle
help in preventing several corneal diseases that are associated
with senescence. Both the SAM R1 and SAM P8 strains were
characterized by an age-dependent decrease in the ECD values
that interestingly resemble the progression of HCECs with
age.  Light  microscopy  and  electron  microscopy  analyses
showed the degenerative and atrophic characteristics of these
aforementioned  strains,  which  are  intriguingly  similar  to
HCECs  progressing  through  the  senescence  process,
including  a  decrease  in  the  number  of  microvilli  and
organelles, a thinning of the endothelium, a thickening of the
Descemet’s membrane, an increase in the number of vacuoles
and pantomorphic cells, and an increase in the size of the cells.
These specific characteristics were more significantly altered
in the SAM P8 strain than in the SAM R1 strain. In addition,
the results from SA-β-Gal staining analysis, which is known
to represent a marker of cellular senescence, indicated that the
number of senescent cells increased in the CECs of these two
mouse  strains  with  an  increase  in  age.  However,  the
characteristic changes were far more obvious in the SAM P8
strain. All of the above results demonstrate that the CECs of
the SAM-R1 and SAM P8 strains enter senescence as they
age, and moreover, the aging process progresses more rapidly
in the CECs of the SAM P8 strain. However, it is still unclear
whether the vascular membrane hyperplasia in CECs of 12-
month-old SAM P8 mice is due to senescence of CECs or is
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753Figure 4. Analysis of scanning electron microscope imaging. Analysis of one-month-old specimens from the SAM R1 and the SAM P8
experimental groups (A and B, respectively) displayed the morphology of endothelial cells, which was hexagonal and uniform, with numerous
microvilli located on the surface. Analysis of six-month-old specimens from the SAM R1 and the SAM P8 experimental groups (C and D,
respectively) showed that the endothelial cells became larger and pantomorphic. Analysis of 12-month-old specimens from the SAM R1 and
the SAM P8 experimental groups (E and F, respectively) showed more polygonal cells, and these cells also became larger. Scale bars: 10
μm.
Molecular Vision 2009; 15:747-761 <http://www.molvis.org/molvis/v15/a77> © 2009 Molecular Vision
754Figure 5. Staining of senescence-associated β-galactosidase activity in corneal endothelial cells of the SAM R1 and the SAM P8 strains at
various ages. The positive stainings are shown in blue. The staining of the SAM R1 strain at one month, six months, and 12 months are shown
(A, C, and E, respectively). The staining of the SAM P8 strain at one month, six months, and 12 months are also displayed (B, D, and F,
respectively). There were few to no positive stainings for SA-β-Gal activity in panels A and B while there were more multifocal and intense
positive stainings in panels C, D, E, and F. Magnification: 400X.
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755just  an  accident.  More  research  is  required  to  detect  this
phenomenon.
Based  on  the  above  results,  we  made  further
investigations on corneal endothelial cellular senescence in
the SAM strains from the molecular level. Many studies have
reported the importance of senescence-related genes such as
p16INK4a, p19ARF, p21WAF1/CIP1, and p53 in cellular senescence.
They can inhibit cell cycle progression and maintain the G1
phase arrest of cells [34]. They are always looked as biological
markers of cell senescence for their accumulation and high
expression in the aged cells [35,36]. Some environmental
stress can also lead to the overexpression of these genes, which
may induce premature cells [37-40]. There were some reports
on the importance of these genes in senescence of CECs in
Figure 6. Average percentage of SA-β-
Gal-positive  cells  at  each  grade  in
various  experimental  groups.  The
classification  standard  of  SA-β-Gal
activity is according to Tatsuya et al.
[49]. This graph shows that few to no
positive  SA-β-Gal  staining  was
observed in the endothelium in corneas
from  younger  mice.  In  corneas  from
older  mice,  the  percentage  of  CECs
staining  positive  for  SA-β-Gal  was
higher in the P8 strain than in the R1
strain.Statistical  analysis  is  shown  in
Table 6.
Figure 7. Immunohistochemical staining of p-ERK 1/2, p16INK4a, p19ARF, p21WAF1/CIP1, and p53 in corneal endothelial cells. The arrows indicate
the positive staining in the endothelial nuclei at various ages of each experimental group A: p-ERK 1/2, SAM R1 strain at one month; B:
p16INK4a, SAM P8 strain at one month; C: p19ARF, SAM P8 strain at 12 months; D: p21WAF1/CIP1, SAM P8 strain at six months; E: p53, SAM
R1 strain at 12 months. F: The negative control incubated with PBS instead of a primary antibody, SAM P8 strain at six months. Magnification:
400X.
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756vitro, but their expression may be influenced by passage,
culture environment, injury, or other factors. Therefore, the
expression of these genes in vivo may not directly be inferred
from  these  in  vitro  findings.  Although  the  proliferative
ability of CECs may be different between different species,
the ECD of rodents decrease with age as it does in human
dynamic  observation  and  intervention  can  be  made
throughout the course of senescence. Therefore, this mouse
model is quite important and irreplaceable in the studies on
aging mechanisms of CECs in vivo.
In this study, immunohistochemical and real-time PCR
analyses  not  only  confirmed  but  also  allowed  for  the
comparison  of  the  relative  expression  levels  of  p16INK4a,
p19ARF,  p21WAF1/CIP1,  and  p53  in  CECs.  An  age-dependent
increase in p16INK4a expression was observed in the SAM R1
strain and in the early stages of senescence in the SAM P8
strain. However, an age-dependent increase in the expression
of p21WAF1/CIP1 and p53 was only observed in the SAM P8
strain. Thus, the p16INK4a and the p53/p21WAF1/CIP1 pathways
should be related to the in vivo process of aging in the CECs
of SAM. However, the reasons for the differential expression
of these signaling pathway components in each strain may be
related to the extent to which aging has progressed and the
relative rate of the different signaling cascades. The SAM R1
strain is characterized as having a normal aging process in
mice such that 12 months are equivalent to roughly two-third
of its entire life span while the SAM P8 strain represents an
Figure 8. Quantitative real-time polymerase chain reaction analyses of mRNA expression of senescence-related genes after normalization to
GAPDH in the corneal endothelial cells of SAM R1 and P8 strains at various ages. A: Quantitative comparison of the fold difference in the
expression of p16INK4a mRNA is shown at various ages in each experimental group. The results indicate that the expression of p16INK4a was
significantly increased from six months old to 12 months old in the SAM R1 strain experimental group (p=0.027 and p=0.000, respectively).
In the SAM P8 strain experimental group, a significant increase was observed at six months (p=0.000 when compared to the one-month-old
control group) and a significant decrease was observed at 12 months (p=0.000 when compared to the value at six months), although comparison
between the 12-month- and 1-month-old values still resulted in a statistically significant increase (p=0.008). B: Quantitative comparison of
the fold difference in the expression of p19ARF mRNA is shown at various ages. The results indicate that the expression of p19ARF mRNA
decreased significantly at six months in the SAM R1 strain experimental group (p=0.000). C: Quantitative comparison of the fold difference
in the expression of p21WAF1/CIP1 mRNA is shown. The results indicated that the expression of p21WAF1/CIP1 was significantly higher at 12
months in the SAM P8 strain experimental group (p=0.007). D: Quantitative comparison of the fold difference in the expression of p53 mRNA
is shown. The results indicate that the expression of p53 decreased significantly at six months of age in the SAM R1 strain experimental group,
although no significant difference was observed at 12 months of age (when compared to the value at one month; p=0.000, p=0.927,
respectively). However, the expression of p53 increased significantly at 12 months of age in the SAM P8 strain experimental group (p=0.000).
There were three individual corneas used in each experimental group, and each cDNA sample had been detected three times. An asterisk
marks a statistically significant difference (p<0.05).
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[41,42]. There is no limitation on number of animals used, andaccelerated senescence mouse model where six months of age
is equivalent to approximately half of its entire life span. The
old donors studied in a report by Song et al. [8] were between
50 and 65 years old, which was equivalent to approximately
half to two-third of a typical human life span. Thus, the results,
which indicated an age-dependent increase in the expression
of p16INK4a at 6 and 12 months of age for the SAM R1 strain
and at six months of age for the SAM P8 strain, were similar
to the aforementioned study in HCECs [8]. These results have
important implications for our hypothesis regarding the aging
program in CECs, specifically that the p16INK4a pathway may
play an important role in early senescence. We have also
observed an age-dependent increase in the expression levels
of  p53  and  p21WAF1/CIP1  in  CECs  of  the  SAM  P8  strain.
However, there were no such differences observed in the
characteristics of HCECs [8]. Species-related differences may
be one of the reasons for this observation. However, we can
still make the assumption that the p53/p21WAF1/CIP1 signaling
pathway  may  cooperate  to  promote  CECs  senescence,
although this would primarily have an effect in the late stages
of  aging.  Considering  the  SAM  P8  strain  represents  a
senescence-accelerated  mouse,  we  also  deduce  that  the
activation  of  the  p53/p21WAF1/CIP1  signaling  pathway  may
Figure 9. Western blot analyses of the
expression  levels  of  the  p-ERK  1/2
protein in the corneal endothelial cells at
various ages of the SAM R1 and SAM
P8  strains.  A:  The  expressions  of  p-
Erk1/2 and Erk1/2 proteins in 1-month-,
6-month-, and 12-month-old specimens
of the SAM-R1 and the SAM P8 strains
are  displayed.  B:  Quantitative
comparison of the fold changes in the
expression  of  p-Erk1/2  after
normalization to the Erk1/2 protein is
shown  at  various  ages  in  each
experimental group. The results show
that p-ERK1/2 significantly increased at
12 months of age in both the R1 and P8
strains,  which  indicate  that  the
activation  level  of  Erk1/2  protein  is
much higher in the late senescent CECs.
There  were  three  individual  corneas
used in each experimental group, and
each protein sample had been detected
three  times.  An  asterisk  marks  a
statistically  significant  difference
(p<0.05).
TABLE 6. THE PERCENTAGE OF SA-Β-GAL-POSITIVE CELLS OF THE CORNEAS IN VARIOUS AGES OF EACH EXPERIMENTAL GROUP.
Groups 1 m (%) 6 m (%) 12 m (%)
R1 1.87±1.64 (n=15) 8.93±8.65 (n=15, p=0.205
versus 1 m)
40.80±20.45 (n=15, *p=0.000
versus 6 m)
P8 2.13±1.06 (n=15) 31.40±22.75 (n=15, *p=0.000
versus 1 m)
56.33±13.32 (n=15, *p=0.000
versus 6 m)
p value (R1 versus P8) p=0.959 *p=0.000 *p=0.003
In the headings, m is the age  in months. In the body of the table, n is the number of fields examined from the three individual
specimens of each experimental group. The percentage of SA-β-Gal-positive cells increased significantly in the 12-month-old
specimen of the R1 strain group while the percentage increased significantly in both the 6-month- to 12-month-old specimens
of the P8 strain group. When comparing the two strain groups, the percentage of SA-β-Gal-positive cells are significantly higher
in both the 6-month- and 12-month-old specimens of the P8 strain than in specimens of the R1 strain group of the same ages.
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758promote  an  accelerated  senescence  in  CECs  during  some
pathological processes.
Interestingly, both p16INK4a and p19ARF are located at the
INK4a locus (one of the most frequently disrupted tumor
suppressor loci in human cancer) [43], and they have both
been shown to act as effectors of senescence in cultured cells
[44]. In addition, their expression levels increase in numerous
tissues with increased age [45,46]. However, in our study, the
expression of p19ARF did not increase with increased age in
either of the two strains and was even shown to decrease in
the SAM R1 strain at 12 months. Until now, there have not
been  any  studies  that  have  probed  the  age-dependent
expression  of  p19ARF  in  CECs  either  in  vivo  or  ex  vivo.
However, in the skeletal muscle and fat tissue of mice lacking
BubR1 (an essential spindle checkpoint protein conserved
among  higher  eukaryotic  organisms),  the  inactivation  of
p16INK4a attenuates both cellular senescence and premature
aging,  and  conversely,  p19ARF  inactivation  exacerbates
cellular  senescence.  These  observations  demonstrate  that
p16INK4a is an effector and that p19ARF is an attenuator of
cellular  senescence  in  these  tissues  [47].  However,
information concerning whether or not p19ARF has the same
effect on senescence in CECs remains unclear. Therefore,
further investigation that specifically compare samples from
human and SAM strains comprising a broader range of ages
are  necessary  to  accurately  characterize  the  senescence
signaling pathway in CECs.
Most studies have indicated that the MAPK signaling
pathway in mammalian systems have shown a transmission
of  mitogenic  signals  that  promotes  proliferation  and
differentiation. However, studies that are more recent have
indicated  that  the  MAPK  signaling  cascade  is  initially
mitogenic  but  eventually  induces  senescence  via  the
activation of the p53 and p16INK4a tumor suppressor in primary
cells  [48].  These  studies  found  that  activated  MEK  (a
component  of  the  MAPK  signaling  cascade)  permanently
arrests  the  primary  murine  fibroblasts  and  initiates
uncontrolled mitogenesis and transformation in cells lacking
either p53 or INK4a. These studies indicated that the cell cycle
arrest induced by the MAPK signaling cascade is permanent
and reflects a bona fide cellular senescence and not an unusual
form of quiescence or differentiation. In our study, we found
that  the  expression  levels  of  the  p-ERK  1/2  proteins  (a
component of the MAPK cascade that had been activated by
phosphorylation) were significantly higher in CECs of older
mice compared with one- and six-month-old mice from each
experimental group. However, it has yet to be determined
whether the activated and upregulated states of Erk1/2 induce
the senescence process of CECs.
In summary, the SAM R1 and the SAM P8 strains are
sufficient models for the study of corneal endothelial cellular
senescence in vivo. The CEC senescence program progresses
more rapidly in the SAM P8 strain than in the SAM R1 strain.
The p16INK4a signaling pathway may induce CEC senescence
in the SAM R1 strain and in early stages of senescence in the
SAM  P8  strain.  However,  the  p53/p21WAF1/CIP1  signaling
pathway may induce CEC senescence in the SAM P8 strain.
We conclude from analysis of these results that the p16INK4a
signaling pathway may play a key role in the early process of
senescence in CECs and that the p53/p21WAF1/CIP1 signaling
pathway may have its principle effect in the late stages of
senescence in CECs. However, it has yet to be determined
whether  MAPK  signaling  pathway  plays  a  role  in  the
senescence process of CECs. Further investigation is needed.
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